Navigation Links
ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
Date:4/14/2008

HAIFA, Israel, April 14 /PRNewswire/ -- ES Vascular Ltd. announced today that it has received a CE Mark approval for its Open Aortic Stapler (OAS) system for mechanical suturing technology of aortic synthetic grafts during open repair of AAA and other aortic reconstructions, enabling commercialization of the device in most European countries. Based on its proprietary stapling technology, the OAS stapler is a unique device that enables one shot stapling of synthetic grafts to aorta in open repair of abdominal and thoracic aneurysmal and occlusive disease, replacing lengthy and cumbersome manual suturing in these major procedures.

"We are very pleased to have received CE Mark for our OAS device and will immediately implement our strategy to make it available in approved countries. Positive clinical data position OAS to be a break-through product for patients and physicians alike," said Shuki Porath, CEO of ES Vascular.

Prof. Ralf Kolvenbach, Chief of Vascular Surgery and Endovascular Therapy at Augusta Hospital in Dusseldorf, Germany and a principal investigator for the OAS clinical trial program, commented, "OAS provides the construction of a geometrically perfect, uniform and standardized anastomosis that will not depend on the skills of the surgeon, is one of the principles lying behind the design of the OAS. This safety and feasibility trial showed that we now have the technology to use aortic stapling in a clinical setting. The aortic stapler can create a uniform staple line between any synthetic vascular prosthesis and the aortic wall. It is a simple, safe, rapid and reliable technique to perform a sutureless, end-to-end anastomosis in patients with aortic aneurysms or occlusive disease."

ES Vascular will be presenting the OAS and other products at the MedtechInsight conference "Investment In Innovation (In3) Europe", Paris, April 29-30.

About OAS System

The OAS system is comprised of applier and implantable staples and also includes specially designed clamp. The OAS device consists of two parts: a barrel shaped head and a handle. The head of the OAS device is pre-loaded with 10 stainless steel (316 LVM) staples that can be fired in one shot from the inside of the aorta to the outside through the synthetic graft. The staples form a pseudo-continuous suturing line, firmly attaching the graft to the aorta. The OAS is available in 16, 18, 20 and 22 mm diameters.

About ES Vascular, Ltd.

ES Vascular Ltd., http://www.esvascular.com, a privately held company, is engaged in the development, licensing and commercialization of its proprietary product line of one-shot, instantaneous anastomotic stapling devices for open, laparoscopic and endovascular abdominal and thoracic aortic surgery and for minimally invasive surgery of SFA. Their use is anticipated to revolutionize vascular surgery resulting in improved clinical outcome, higher patient benefit and decreased costs.

ES Vascular will be presenting the OAS and other products at the MedtechInsight conference "Investment In Innovation (In3) Europe", Paris, April 29-30.

Contact:

Shuki Porath, CEO,

+972-544-336-486,

Shuki@esvacular.com.


'/>"/>
SOURCE ES Vascular Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
2. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
3. Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
4. First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies OmniWave(TM) Endovascular System
5. LeMaitre Vascular to Participate in 28th Annual Cowen and Company Health Care Conference
6. BioVascular, Inc. Expands Executive Team
7. HealthAware Introduces Its VascularAware Cardiovascular Disease Module
8. Topspin Medical Announces First Commercial Installation of the Cathamaran(TM) Intravascular MRI System
9. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
10. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
11. The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... solutions for clinical development reported today that it is launching two new additions ... company will be demonstrating new capabilities at the DIA 2017 Annual Meeting in ...
(Date:6/16/2017)... ... , ... CTNext , Connecticut’s go-to resource for entrepreneurial support, today announced ... Chelsea Piers in Stamford. , Nine finalists, all of whom are Connecticut-based companies and ... to secure $10,000 awards to help support business growth. The winners included:, ...
(Date:6/15/2017)... ... 2017 , ... DuPont Industrial Biosciences (DuPont) announced that Jan ... Bloomberg’s 2017 Sustainable Business Summit: Seattle this Thursday, June 15, at 4:10 ... panel titled “Developing a Corporate Renewables Strategy.” , “Consumers want to buy ...
(Date:6/14/2017)... ... ... Diagenode, a leading global provider for complete solutions for ... technology specific for ChIP-sequencing from the CeMM for low ... (ChIP-seq) allows the study of histone modifications and transcription ...
Breaking Biology Technology:
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
Breaking Biology News(10 mins):